Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sanofi ADR stock

Learn how to easily invest in Sanofi ADR stock.

Sanofi ADR is a drug manufacturers-general business based in the US. Sanofi ADR shares (SNY) are listed on the NASDAQ and all prices are listed in US Dollars. Sanofi ADR employs 95,442 staff and has a trailing 12-month revenue of around $44.3 billion.

How to buy Sanofi ADR stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – SNY. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Sanofi ADR stock price (NASDAQ: SNY)

Use our graph to track the performance of SNY stocks over time.

Sanofi ADR shares at a glance

Information last updated 2023-01-25.
Latest market close$48.49
52-week range$36.91 - $56.08
50-day moving average $46.98
200-day moving average $47.15
Wall St. target price$64.00
PE ratio 17.6679
Dividend yield $3.33 (3.59%)
Earnings per share (TTM) $2.77

Buy Sanofi ADR stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Sanofi ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sanofi ADR price performance over time

Historical closes compared with the close of $48.49 from 2023-01-27

1 week (2023-01-23) -0.29%
1 month (2022-12-30) 0.12%
3 months (2022-10-31) 12.17%
6 months (2022-07-29) -2.43%
1 year (2022-01-31) -6.75%
2 years (2021-01-29) 2.71%
3 years (2020-01-31) 0.46%
5 years (2018-01-30) 8.21%

Is Sanofi ADR stock undervalued or overvalued?

Valuing Sanofi ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sanofi ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Sanofi ADR's P/E ratio

Sanofi ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Sanofi ADR shares trade at around 18x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Sanofi ADR's PEG ratio

Sanofi ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6501. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sanofi ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.


Sanofi ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.2 billion.

The EBITDA is a measure of a Sanofi ADR's overall financial performance and is widely used to measure a its profitability.

Sanofi ADR financials

Revenue TTM $44.3 billion
Operating margin TTM 23.98%
Gross profit TTM $26.9 billion
Return on assets TTM 4.91%
Return on equity TTM 10%
Profit margin 14.45%
Book value $28.34
Market capitalisation $123.9 billion

TTM: trailing 12 months

Sanofi ADR share dividends


Dividend payout ratio: 48.2% of net profits

Recently Sanofi ADR has paid out, on average, around 48.2% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sanofi ADR shareholders could enjoy a 3.59% return on their shares, in the form of dividend payments. In Sanofi ADR's case, that would currently equate to about $3.33 per share.

While Sanofi ADR's payout ratio might seem fairly standard, it's worth remembering that Sanofi ADR may be investing much of the rest of its net profits in future growth.

Sanofi ADR's most recent dividend payout was on 26 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 25 May 2022 (the "ex-dividend date").

Have Sanofi ADR's shares ever split?

Sanofi ADR's shares were split on a 5:1 basis on 29 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sanofi ADR shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Sanofi ADR shares which in turn could have impacted Sanofi ADR's share price.

Sanofi ADR share price volatility

Over the last 12 months, Sanofi ADR's shares have ranged in value from as little as $36.91 up to $56.0802. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sanofi ADR's is 0.4349. This would suggest that Sanofi ADR's shares are less volatile than average (for this exchange).

Sanofi ADR overview

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange.

Frequently asked questions

What percentage of Sanofi ADR is owned by insiders or institutions?
Currently 0.006% of Sanofi ADR shares are held by insiders and 10.286% by institutions.
How many people work for Sanofi ADR?
Latest data suggests 95,442 work at Sanofi ADR.
When does the fiscal year end for Sanofi ADR?
Sanofi ADR's fiscal year ends in December.
Where is Sanofi ADR based?
Sanofi ADR's address is: 54, Rue La BoEtie, Paris, France, 75008
What is Sanofi ADR's ISIN number?
Sanofi ADR's international securities identification number is: US80105N1054
What is Sanofi ADR's CUSIP number?
Sanofi ADR's Committee on Uniform Securities Identification Procedures number is: 80105N204

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site